Intelligent automation is providing pharma and biotech companies, and their contract manufacturing partners, major gains with minimised risk compared with previous waves of automation
Are you aware that 94% of the pharma professionals surveyed in the AI 2020: The Future of Drug Discovery Report expect intelligent technologies to have a noticeable impact on the pharmaceutical industry during the next 2 years?
A new report takes an in-depth look at the intelligent enterprise investments, trends and challenges that are reshaping drug discovery and setting the stage for a manufacturing revolution.
We asked the following questions:
Hear from Merck, Medtronic and more as they discuss these topics at the Intelligent Automation in Pharma Forum this April (23-25) in Boston, MA, USA!
Our limited $995 introductory passes are expiring soon; make sure you purchase your pass to the event by Friday 19 January to get the lowest price possible!